Tolerability Allowing News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Tolerability Allowing. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Tolerability Allowing Today - Breaking & Trending Today

Ocuphire Announces Topline Results from ZETA-1 Phase 2 Trial of Oral APX3330 in Diabetic Retinopathy and Plans for End-of-Phase 2 Meeting with FDA

Published: January 25, 2023

Oral APX3330 Achieved Statistical Significance on a Key Pre-specified Secondary Endpoint of Preventing Clinically Meaningful Progression of Diabetic Retinopathy after 24 Weeks of Treatment Oral... | January 25, 2023

Source: marketscreener.com

Related Topics:

Bret ShapiroCorey DavisOcuphire PharmaMina SoochPeterk KaiserEarly Treatment Diabetic Retinopathy Study Research GroupMacula Society Annual MeetingCole Eye InstituteCleveland Clinic FoundationGlobenewswire IncOcuphire Pharma IncStatistical SignificanceKey Pre Specified Secondary EndpointPreventing Clinically Meaningful ProgressionDiabetic RetinopathyFavorable SafetyTolerability AllowingPotential Attractive Non Invasive OptionBoth EyesWebcast TodayEye InstituteClinic FoundationClinical ImportanceDiabetic Retinopathy SeverityTreatment Diabetic Retinopathy Study Research